Share Name Share Symbol Market Type Share ISIN Share Description
Croda International Plc LSE:CRDA London Ordinary Share GB00BJFFLV09 ORD 10.609756P
  Price Change % Change Share Price Shares Traded Last Trade
  76.00 1.24% 6,212.00 226,723 16:35:24
Bid Price Offer Price High Price Low Price Open Price
6,188.00 6,192.00 6,224.00 6,150.00 6,212.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 1,377.70 302.30 172.80 35.9 8,187
Last Trade Time Trade Type Trade Size Trade Price Currency
17:45:57 O 1,469 6,212.00 GBX

Croda (CRDA) Latest News

More Croda News
Croda Takeover Rumours

Croda (CRDA) Discussions and Chat

Croda Forums and Chat

Date Time Title Posts
24/7/201822:20Croda Intl (CRDA) One to Watch on Wednesday -
23/7/201415:31TipTv analyses the prospects of Croda International PLC (CRDA)-
25/7/201220:28CRODA BACK TO Ј7253
05/2/200714:35Strong Outlook98

Add a New Thread

Croda (CRDA) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-09-23 17:28:586,212.001,46991,254.28O
2020-09-23 16:45:576,185.8060437,362.23O
2020-09-23 16:45:576,185.802,033125,757.31O
2020-09-23 16:09:236,212.311,809112,380.71O
2020-09-23 15:35:246,212.00100,3626,234,487.44UT
View all Croda trades in real-time

Croda (CRDA) Top Chat Posts

Croda Daily Update: Croda International Plc is listed in the Chemicals sector of the London Stock Exchange with ticker CRDA. The last closing price for Croda was 6,136p.
Croda International Plc has a 4 week average price of 5,770p and a 12 week average price of 5,196p.
The 1 year high share price is 6,298p while the 1 year low share price is currently 3,814p.
There are currently 131,794,934 shares in issue and the average daily traded volume is 298,083 shares. The market capitalisation of Croda International Plc is £8,187,101,300.08.
broadwood: Share price getting a nice boost Berenberg Croda International PLC 23/01/2018 Upgrades Hold Buy 2 4,150.00 5,000.00 4,469.00 850 2
erogenous jones: broadwood, the market per se is up quite strongly today. For the last few years there has been a wealth of cash "created" in the guise of quantative easing. That it is only now starting to be seen in some capital projects (road re-furbishment rail upgrade etc) means that the knock on effect to the major suppliers to such projects are starting to build their order books. This has yet to filter down to the guys on the ground floor as there are still redundancies being announced, but these are more to do with re-deployment to prepare for a changed European Union, one that may or may not have the UK as a trading partner. Croda deals with just about every type of industry and rising sentiment in markets and governments will manifest in a rising share price for CRDA
miata: Interim dividend increased 8.4% to 29.0p (2012: 26.75p). The company has rewarded investors with a sharp rise in its share price in the last five years - up more than +550%. For the last six months, operating profit climbs +4.2% to £139.1m while profit before tax climbs +6.3% to £133.1m. In terms of second quarter performance, operating profit climbs +4.4% to £71.1m with profit before tax up +6.1% to £68.0m. Consumer Care sales driven by double digit growth across Personal Care and Health Care in Europe says Croda. "Although the challenging trading environment," says chairman Martin Flower, "has inevitably held back certain parts of the business, our leading positions in niche markets and steadfast commitment to innovation are reflected in improved profits and margins in all three business divisions."
broadwood: Chemical peers Johnson Matthey and Croda International were lifted higher after Credit Suisse upgraded the companies from 'neutral' to 'outperform' and from 'underperform' to 'neutral', respectively, saying: "Both stocks had disappointing guidance and strongly negative share price reactions. We felt negative short-term fundamentals were thus fairly reflected in the share price
miata: Barclays Capital: Analyst Andreas Heine said: "Croda is best in class in marketing innovative solutions in niche markets. "Margins of 26% are industry leading. The recent third quarter results were a rare miss of expectations. "Even then, profits increased versus last year. The company's product mix will continue to improve due to innovation, and we increase our margin assumptions for Performance Technologies. "Croda is still not exactly cheap, in our view. We have become more positive on the Performance Technologies earnings prospect and raise our target price to 2,260. "Due to our higher target price and recent share price correction, we upgrade the stock to equal-weight."
broadwood: Broker Forecasts have started presenting the recs in a different way. Its now - Prev Target, New Target, Share price.
broadwood: The chemicals company Croda International supplies materials for a range of industries from skin care to pesticides, from car maintenance, to textiles, printing inks and technology for the oil and gas industries. The dividend is strong, raised 50 per cent at the interims to 9.75p, and the stock trades on an estimated price of 13.5 times full-year 2011 earnings, which looks justified. The shares retreated off yesterday's announcement, which certainly looks like a buying opportunity says the Independent. Croda has always said that it will use excess cash to fund acquisitions or, failing that, share buy-backs. There are precious few of the former in prospect, while the chances of the latter has fuelled this year's share price rise. The shares have risen by a third since the company's interim results, at the end of July, and now sell on more than 13 times' next year's expected earnings. That feels about right. Hold, but buy on weakness, says the Times.
garethcoulson: Croda has the right elements to enable it to flourish By Garry White Last Updated: 8:47PM GMT 08 Dec 2008 Croda International 389¾p +10 Questor says BUY Good companies as well as bad companies have seen their share price hammered over the last year. Today I want to highlight one of the good ones. Croda International is a world leader in the manufacture of speciality chemicals. It is likely to see some hit from the parlous state of the global economy, but Questor still regards it as a defensive business. The shares have fallen 46pc from their peak on May 5 2008 and Questor believes that this has created an opportunity to get in ahead of a strong set of full-year numbers. The group manufactures chemicals for the healthcare businesses, the cosmetic industry and crop care products that are used in herbicides and insecticides. Its other products include lubricants for the oil and gas industry, solutions to help in textile processing and polymers for plastics and packaging, plus many, many more. It also supplies ingredients for the high-end cosmetics sold by luxury brands such as Chanel and Estée Lauder. "We appeal to two things that will never go away – vanity and ageing," Croda chief executive Mike Humphrey said after its last results statement. Around 75pc of group earnings come from its consumer care operations, mostly low-ticket defensive items. Its industrial products cover a wide range of sectors, which should provide some earnings protection next year – although total volumes are likely to fall. The latest full earnings statement covers the six-month period to June 30 2008. Despite the cost inflation in this period, the company managed to post an increase in pre-tax profits of 64.1pc. When the performance of discontinued businesses is stripped out, pre-tax profits actually jumped a stunning 90.3pc. There was a one-off spike in glycerine prices, which flattered the results in the period. The spike provided an additional £4.9m to earnings, constituting just over 9pc of total profits in the period. The disposal of non-core businesses has also reduced net debt, which stood at £364.7m at the end of September. Disposals in the first half included the sale of Baxenden Chemicals in February 2008 to Chemtura for £13m and its Chicago Oleochemical business was sold to HIG Capital in May 2008 for £45.1m. The company managed to fully recover the cost of increased raw materials prices in the first half. However, input costs are now likely to move lower, which should help to boost margins. Of course, customers will be demanding that these cost savings are passed on, but Questor expects that the company will not transfer 100pc of the reduction, which should provide a cushion from falling volumes. The currency markets are also moving in the company's favour – so this should help boost full-year numbers, which are expected to be released in February 2009. So far this year, sales and earnings have been boosted by around 10pc by currency movements. Collins Stewart has calculated that if exchange rates stayed at their current rate, earning in 2009 could see a 15pc boost. However, Questor expects that the pound may slide further in the next six months – providing an even greater currency-related gain. The UK contributes less than 10pc to total sales, with around 50pc coming from Europe and 25pc from the Americas. The company's latest trading update was issued at the start of November – and management oozed confidence. It said global demand for its core products remained robust, with the personal care and crop care sectors showing strong growth. For the three months ended September 30 2008, sales excluding disposals were £246.7m, up 25.2pc from the corresponding period last year. Pre-tax profit on the same basis was 73.2pc higher at £24.6m due to sales increase, synergies realised from the acquisition of Uniqema, favourable currency translation and a reduced interest charge. Croda bought Uniqema from ICI in September 2006 and it is still generating synergies from the complimentary businesses. The company also said that, on a constant currency basis, Croda's average selling price per tonne increased 20.5pc year on year. This reflects not only price increases but also favourable mix from shedding low-quality businesses and the higher sales value of the turnover formerly carried out by third-party distributors. In the year to December 30 2008, pre-tax profits are expected to jump 61pc to £98.13m and earnings per share are forecast to rise 23pc to 48p. This leaves the shares trading on a current-year forward multiple of just 8 times. This looks far too low. This is exactly the type of company that Questor is looking for. The board has proved its effectiveness at cost management and the group is well diversified in different markets – from personal care to oil and gas products to crop management. The group generates more than 90pc of its sales abroad, so it will see benefits from a weak pound. The group is also very cash generative, with free cash flow in the first half of 2008 jumping to £63.9m – 132pc ahead of the first half of 2007. Questor also likes dividends – and Croda's pay-out looks pretty secure. In 2007, its dividend cover on continuing operations was more than two times. The full-year pay-out for 2008 expected to rise to 18.9p from 15.75p last year, which implies a healthy dividend yield of 4.8pc. Even if there was no increase in the dividend, the shares are still yielding 4pc. With the company ticking all the right investment boxes, Croda shares are a definite buy.
stoic warrior: Good results, increased divi, share price may now be breaking out ...
Croda share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200924 02:15:56